ARCHIVES

New DRCCA Board Skeptical Of CIs renewal, Proposal For Cytopathology

This article is from The Cancer Letter archive.

Vol. 06 No. 38 | September 26, 1980

Download PDF Visit The Full Archive

Related Articles

Nexavar Improves PFS In Phase III Trial

January 25, 2013

Also in this 8-page issue: The Cancer Letter wins two awards for its “authoritative examination” of NCI.

June 11, 2004

In Brief: Satcher Confirmed For U.S. Surgeon General; Bishop Selected As Chancellor Of UCSF

February 13, 1998

NCI-Approved Clinical Trials

February 24, 2006

PCORI Approves $54.8 Million For Clinical Effectiveness Research

August 1, 2014

CLF Makes Appointments To Board; Stovall Wins Award.

April 20, 2001